Mayo Working with Start-Ups

The Mayo Clinic Platform_Accelerate program has been launched with four Artificial Intelligence (AI) health tech startups. The 20 week program will help four AI companies get market ready.

The Mayo Clinic Platform will enable new knowledge, new solutions, and new technologies through collaborations with health technology innovators to create a healthier world. The program offers participants access to Mayo Clinic experts in regulatory, clinical, technology, and business domains with a focus on AI model validation and clinical readiness. Technology experts from Google and Epic will also provide workshops for the participants.

Participants will:

  • Work with data science experts to delineate AI model requirements
  • Check for fairness and bias in their AI models
  • Gain understanding of FDA clearance pathways
  • Access de-identified Mayo clinic patient data in a secure environment
  • Conduct model validation with guidance from data science experts
  • Plan clinical validation studies, such as clinical simulation or clinical trials
  • Explore eligibility to partner with Mayo Clinic Platform

 

For example, the four AI participants will explore ways to improve healthcare areas and include:

 

  • cliexa based in Denver, aims to transform patient-centered data into actionable insights for people with cardiovascular conditions and multiple chronic diseases such as diabetes
  • Quadrant Health based in N.Y., will analyze EHRs and patient messaging data to triage messages and predict patient harm before it occurs
  • SciencelO based in Boston and N.Y., will develop tools for organizing data to help streamline care and reduce the administrative burden for physicians
  • Seer Medical based in Melbourne Australia, will use data to refine and test their home-based epilepsy diagnostics and management models, as well as look for digital biomarkers to predict seizures

 

“We are helping participants take a crucial step in their growth trajectory by providing startups with a disciplined focus on model validation and clinical readiness to show product value,” reports Eric Harnisch, VP of Partner Programs for the Mayo Clinic Platform.

A waitlist is open for the second Mayo Clinic Platform_Accelerate cohort. which is planned to begin in summer 2022.

Go to https://mayoclinicplatform.org/accelerate for more information on the Mayo Clinic Platform_Accelerate.